Critical appraisal of the use of alpha lipoic acid (thioctic acid) in the treatment of symptomatic diabetic polyneuropathy

References

• ShawJESicreeRAZimmetPZGlobal estimates of the prevalence of diabetes for 2010 and 2030Diabetes Res Clin Pract20108741419896746
   PubMed Web of Science ®Google Scholar
• RutkoveSBA 52-year-old woman with disabling peripheral neuropathy: review of diabetic polyneuropathyJAMA20093021451145819738078
   PubMed Web of Science ®Google Scholar
• TraceyJADyckJBThe spectrum of diabetic neuropathiesPhys Med Rehabil Clin N Am200819
   Web of Science ®Google Scholar
• SugimotoKMurakawaYSimaAFDiabetic neuropathy – a continuing enigmaDiabetes Metab Res Rev20001640843311114101
   PubMed Web of Science ®Google Scholar
• DyckPJKratzKMKarnesJLThe prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy StudyNeurology1993438178248469345
   PubMed Web of Science ®Google Scholar
• GoreMBrandenburgNDukesEPain severity in diabetic peripheral neuropathy is associated with patient functioning, symptom levels of anxiety and depression, and sleepJ Pain Symp Manage200530374385
   PubMed Web of Science ®Google Scholar
• GoreMBrandenburgNAHoffmanDLBurden of illness in painful diabetic peripheral neuropathy: the patients’ perspectivesJ Pain2006789290017157775
   PubMed Web of Science ®Google Scholar
• GalerBSGianasAJensenMPPainful diabetic polyneuropathy: epidemiology, pain description, and quality of lifeDiabetes Res Clin Pract20004712312810670912
   PubMed Web of Science ®Google Scholar
• McDermottAMToelleTRRowbothamDJThe burden of neuropathic pain: results from a cross-sectional surveyEur J Pain20061012713516310716
   PubMed Web of Science ®Google Scholar
• AbbottCAVileikyteLWilliamsonSMulticenter study of the incidence of and predictive risk factors for diabetic neuropathic foot ulcerationDiabetes Care199821107110759653597
   PubMed Web of Science ®Google Scholar
• CoppiniDVBotwellPAWengCShowing neuropathy is related to increased mortality in diabetic patients – a survival analysis using an accelerated failure time modelJ Clin Epidemiol20005351952310812325
   PubMed Web of Science ®Google Scholar
• VallianouNEvangelopoulosAKoutalasPAlpha-lipoic acid and diabetic neuropathyRev Diabet Stud2009623023620043035
   PubMedGoogle Scholar
• BaydasGDonderEKilibozMNeuroprotection by alpha-lipoic acid in streptozotocin-induced diabetesBiochemistry (Mosc)2004691001100515521814
   PubMed Web of Science ®Google Scholar
• PackerLKraemerKRimbachGMolecular aspects of lipoic acid in the prevention of diabetes complicationsNutrition20011788889511684397
   PubMed Web of Science ®Google Scholar
• ArgoffCEBackonjaM-MBelgradeMConsensus Guidelines: treatment planning and optionsMayo Clin Proc2006814 SupplS122516608049
   PubMed Web of Science ®Google Scholar
• KuritzkyLManaging diabetic peripheral neuropathic pain in primary careJ Fam Pract2010595 SupplS152220544053
   PubMed Web of Science ®Google Scholar
• The Diabetes Control and Complications Trial Research GroupThe effect of intensive diabetes therapy on the development and progression of neuropathyAnn Intern Med19951225615687887548
   PubMed Web of Science ®Google Scholar
• AmthorK-FDahl-JorgensenKBergTJThe effect of 8 years of strict glycaemic control on peripheral nerve function in IDDM patients: the Oslo StudyDiabetologica199437579584
   PubMed Web of Science ®Google Scholar
• ZieglerDPainful diabetic neuropathy: treatment and future aspectsDiabetes Metab Res Rev200824Suppl 1S525718395890
   PubMed Web of Science ®Google Scholar
• AmetovASBarinovADyckPJThe sensory symptoms of diabetic polyneuropathy are improved with alpha-lipoic acid: the SYDNEY trialDiabetes Care20032677077612610036
   PubMed Web of Science ®Google Scholar
• SnellEEStrongFMPetersonWHGrowth factors for bacteria: Fractionation and properties of an accessory factor for lactic acid bacteriaBiochem J1937311789179916746518
   PubMedGoogle Scholar
• PohZXGohKPA current update on the use of alpha lipoic acid in the management of type 2 diabetes mellitusEndocr Metab Immune Disord Drug Targets2009939239819601918
   PubMedGoogle Scholar
• ReedLJDeBuskBGGunsalusICHornbergerCSJrCrystalline alpha lipoic acid; acetalytic agent associated with pyruvate dehydrogenaseScience1951114939414854913
   PubMed Web of Science ®Google Scholar
• ReedLJThe chemistry and function of lipoic acidAdv Enzymol Relat Subj Biochem19571831934713444113
   PubMedGoogle Scholar
• PackerLTritschlerHJWesselKNeuroprotection by the metabolic antioxidant alpha-lipoic acidFree Radic Biol Med1997223593788958163
   PubMed Web of Science ®Google Scholar
• DimpfelWSpulerMPierauFKThioctic acid induces dose-dependent sprouting of neurites in cultured rat neuroblastoma cellsDev Pharmacol Ther1990141931992114274
   PubMedGoogle Scholar
• NickanderKKMcPheeBRLowPAAlpha-lipoic acid: antioxidant potency against lipid peroxidation of neural tissues in vitro and implications for diabetic neuropathyFree Radic Biol Med1996216316398891666
   PubMed Web of Science ®Google Scholar
• NagamatsuMNickanderKKSchmelzerJDLipoic acid improves nerve blood flow, reduces oxidative stress, and improves distal nerve conduction in experimental diabetic neuropathyDiabetes Care199518116011677587852
   PubMed Web of Science ®Google Scholar
• ShayKPMoreauRFSmithEJAlpha-lipoic acid as a dietary supplement: molecular mechanisms and therapeutic potentialBiochim Biophys Acta200917901149116019664690
   PubMed Web of Science ®Google Scholar
• SinghUJialalIAlpha-lipoic acid supplementation and diabetesNutr Rev20086664665719019027
   PubMed Web of Science ®Google Scholar
• Breithaupt-GroglerKNiebchGSchneiderEDose-proportionality of oral thioctic acid-coincidence of assessments via pooled plasma and individual dataEur J Pharm Sci19998576510072479
   PubMed Web of Science ®Google Scholar
• MijnhoutGSAlkhalafAKleefstraNAlpha lipoic acid: a new treatment for neuropathic pain in patients with diabetesNeth J Med20106815816220421656
   PubMed Web of Science ®Google Scholar
• Ltd. PMPriceMe – Online Shopping and Price Comparison New Zealand2011 http://www.priceme.co.nz/search.aspx?q=alpha+lipoic+acidAccessed April 24, 2011
   Google Scholar
• ZieglerDAmetovABarinovAOral treatment with alpha-lipoic acid improves symptomatic diabetic polyneuropathy: the SYDNEY 2 trialDiabetes Care2006292365237017065669
   PubMed Web of Science ®Google Scholar
• RuhnauKJMeissnerHPFinnJREffects of 3-week oral treatment with the antioxidant thioctic acid (alpha-lipoic acid) in symptomatic diabetic polyneuropathyDiabet Med1999161040104310656234
   PubMed Web of Science ®Google Scholar
• ZieglerDHanefeldMRuhnauKJTreatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a 7-month multicenter randomized controlled trial (ALADIN III Study). ALADIN III Study Group. Alpha-Lipoic Acid in Diabetic NeuropathyDiabetes Care1999221296130110480774
   PubMed Web of Science ®Google Scholar
• ZieglerDHanefeldMRuhnauKJTreatment of symptomatic diabetic peripheral neuropathy with the anti-oxidant alpha-lipoic acid. A 3-week multicentre randomized controlled trial (ALADIN Study)Diabetologia199538142514338786016
   PubMed Web of Science ®Google Scholar
• TangJWingerchukDMCrumBAAlpha-lipoic acid may improve symptomatic diabetic polyneuropathyNeurologist20071316416717495764
   PubMed Web of Science ®Google Scholar
• DyckPJDetection, characterization, and staging of polyneuropathy: assessed in diabeticsMuscle Nerve19881121323277049
   PubMed Web of Science ®Google Scholar
• ZieglerDNowakHKemlplerPTreatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a metaanalysisDiabetes200421114121
   Web of Science ®Google Scholar
• BiewengaGHaenenGRBastAThe role of lipoic acid in the treatment of diabetic polyneuropathyDrug Metab Rev199729102510549421684
   PubMed Web of Science ®Google Scholar
• ReljanovicMReichelGRettKTreatment of diabetic polyneuropathy with the antioxidant thioctic acid (alpha-lipoic acid): a two year multicenter randomized double-blind placebo-controlled trial (ALADIN II). Alpha Lipoic Acid in Diabetic NeuropathyFree Radic Res19993117117910499773
   PubMed Web of Science ®Google Scholar
• ZieglerDPainful diabetic neuropathy: advantage of novel drugs over old drugs?Diabetes Care200932Suppl 2S41441919875591
   PubMed Web of Science ®Google Scholar
• RuessmannHJSwitching from pathogenetic treatment with alpha-lipoic acid to gabapentin and other analgesics in painful diabetic neuropathy: a real-world study in outpatientsJ Diabetes Complications20092317417718403218
   PubMed Web of Science ®Google Scholar
• FarvidMSHomayouniFAmiriZImproving neuropathy scores in type 2 diabetic patients using micronutrients supplementationDiabetes Res Clin Pract.2011 [Epub ahead of print]
   PubMed Web of Science ®Google Scholar
• TutuncuNBBayraktarMVarliKReversal of defective nerve conduction with vitamin E supplementation in type 2 diabetes: a preliminary studyDiabetes Care199821191519189802743
   PubMed Web of Science ®Google Scholar
• SuksomboonNPoolsupNSinprasertSEffects of vitamin E supplementation on glycaemic control in type 2 diabetes: systematic review of randomized controlled trialsJ Clin Pharm Ther201136536321198720
   PubMed Web of Science ®Google Scholar
• ScottJKingGOxidative stress and antioxidant treatment in diabetesAnn N York Acad Sci20041031204213
   PubMed Web of Science ®Google Scholar